Works matching DE "DYSLIPIDEMIA"
Results: 5000
Mediterranean diet and hypertension: relationship between adherence to a Mediterranean diet and arterial hypertension.
- Published in:
- BMC Nutrition, 2025, v. 11, n. 1, p. 1, doi. 10.1186/s40795-025-01025-1
- By:
- Publication type:
- Article
Association of diabetes mellitus and dyslipidaemias in the Tehran population.
- Published in:
- Eastern Mediterranean Health Journal, 2008, v. 14, n. 3, p. 647
- By:
- Publication type:
- Article
Persistent Dyslipidemia in Austrian patients treated with statins for primary and secondary prevention of atherosclerotic events - Results of the dyslipidemia international study (DYSIS).
- Published in:
- Wiener Klinische Wochenschrift, 2011, v. 123, n. 19/20, p. 611, doi. 10.1007/s00508-011-0057-1
- By:
- Publication type:
- Article
Two Neglected Biologic Risk Factors in Bone Grafting and Implantology: High Low-Density Lipoprotein Cholesterol and Low Serum Vitamin D.
- Published in:
- Journal of Oral Implantology, 2014, v. 40, n. 1, p. 110, doi. 10.1563/AAID-JOI-D-13-00062
- By:
- Publication type:
- Article
Relationship Between Smoking and Metabolic Syndrome in Men with Diabetes Mellitus.
- Published in:
- Metabolic Syndrome & Related Disorders, 2014, v. 12, n. 1, p. 70, doi. 10.1089/met.2013.0110
- By:
- Publication type:
- Article
Prevalence and Risk Factors of Elevated Blood Pressure, Overweight, and Dyslipidemia in Adolescent and Young Adults in Rural Nepal.
- Published in:
- Metabolic Syndrome & Related Disorders, 2013, v. 11, n. 5, p. 319, doi. 10.1089/met.2013.0016
- By:
- Publication type:
- Article
Posttraumatic Stress Disorder and Metabolic Syndrome: More Questions Than Answers.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
The ApoB/A-I Ratio and Metabolic Syndrome in Prepubertal Children.
- Published in:
- Metabolic Syndrome & Related Disorders, 2013, v. 11, n. 2, p. 115, doi. 10.1089/met.2012.0124
- By:
- Publication type:
- Article
High Prevalence of Metabolic Syndrome in Young Hispanic Women: Findings from the National Sister to Sister Campaign.
- Published in:
- Metabolic Syndrome & Related Disorders, 2013, v. 11, n. 2, p. 81, doi. 10.1089/met.2012.0109
- By:
- Publication type:
- Article
Harmonizing the Diagnosis of Metabolic Syndrome-Focusing on Abdominal Obesity.
- Published in:
- Metabolic Syndrome & Related Disorders, 2013, v. 11, n. 2, p. 102, doi. 10.1089/met.2012.0060
- By:
- Publication type:
- Article
Managing the Dyslipidemia of Metabolic Syndrome: Beyond Statin Therapy.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Comparing Abilities of Different Lipid Measures in Diagnosis of Insulin Resistance: A Survey of Risk Factors of Non-Communicable Diseases (SuRFNCD-2007) Study.
- Published in:
- Metabolic Syndrome & Related Disorders, 2012, v. 10, n. 1, p. 63, doi. 10.1089/met.2011.0002
- By:
- Publication type:
- Article
Review of Studies on the Effect of Bile Acid Sequestrants in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Metabolic Syndrome & Related Disorders, 2010, v. 8, n. S1, p. S-9, doi. 10.1089/met.2010.0087
- By:
- Publication type:
- Article
The Role of Bile Acid Sequestrants in the Management of Type 2 Diabetes Mellitus.
- Published in:
- Metabolic Syndrome & Related Disorders, 2010, v. 8, n. S1, p. S-15, doi. 10.1089/met.2010.0095
- By:
- Publication type:
- Article
Bile Acid Sequestrants: Glucose-Lowering Mechanisms.
- Published in:
- Metabolic Syndrome & Related Disorders, 2010, v. 8, n. S1, p. S-3, doi. 10.1089/met.2010.0096
- By:
- Publication type:
- Article
The Role of Bile Acid Sequestrants in the Management of Type 2 Diabetes Mellitus: Summary and Future Directions.
- Published in:
- Metabolic Syndrome & Related Disorders, 2010, v. 8, n. S1, p. S-23, doi. 10.1089/met.2010.0104
- By:
- Publication type:
- Article
Improvement in the High-Fat Diet-Induced Dyslipidemia and Adiponectin Levels by Fish Oil Feeding Combined with Food Restriction in Obese KKAy Mice.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2012, v. 76, n. 5, p. 1011, doi. 10.1271/bbb.110743
- By:
- Publication type:
- Article
Effect of a 0.6% Energy trans Fatty Acid Intake on Serum Cholesterol Concentrations in Healthy Young Japanese Subjects.
- Published in:
- Bioscience, Biotechnology & Biochemistry, 2011, v. 75, n. 11, p. 2243, doi. 10.1271/bbb.110420
- By:
- Publication type:
- Article
Rheumatoid Arthritis.
- Published in:
- Current Medical Literature: Rheumatology, 2012, v. 31, n. 4, p. 126
- Publication type:
- Article
Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 3, p. 493, doi. 10.1007/s10557-022-07413-0
- By:
- Publication type:
- Article
Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 1, p. 119, doi. 10.1007/s10557-022-07386-0
- By:
- Publication type:
- Article
Cardiovascular Event Rates in Statin-Treated Korean Patients with Cardiovascular Disease: Estimates from a Real-World Population Using Electronic Medical Record Data.
- Published in:
- Cardiovascular Drugs & Therapy, 2023, v. 37, n. 1, p. 129, doi. 10.1007/s10557-021-07255-2
- By:
- Publication type:
- Article
Dyslipidemia, chronic kidney disease, atherosclerotic cardiovascular disease, and statins.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 3, p. 569, doi. 10.1007/s10557-021-07284-x
- By:
- Publication type:
- Article
LDL Cholesterol Reduction Variability with Different Types and Doses of Statins in Monotherapy or Combined with Ezetimibe. Results from the Spanish Arteriosclerosis Society Dyslipidaemia Registry.
- Published in:
- Cardiovascular Drugs & Therapy, 2022, v. 36, n. 2, p. 301, doi. 10.1007/s10557-020-07137-z
- By:
- Publication type:
- Article
Association of blood cell counts with the risk of olanzapine‐ or clozapine‐induced dyslipidemia in Chinese schizophrenia patients.
- Published in:
- Human Psychopharmacology: Clinical & Experimental, 2019, v. 34, n. 4, p. N.PAG, doi. 10.1002/hup.2699
- By:
- Publication type:
- Article
A digest of the Evidence-Based Clinical Practice Guideline for Nephrotic Syndrome 2020.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 12, p. 1277, doi. 10.1007/s10157-021-02098-5
- By:
- Publication type:
- Article
Effects of LDL apheresis on proteinuria in patients with diabetes mellitus, severe proteinuria, and dyslipidemia.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 1, p. 1, doi. 10.1007/s10157-020-01959-9
- By:
- Publication type:
- Article
Influence of post-disaster evacuation on incidence of hyperuricemia in residents of Fukushima Prefecture: the Fukushima Health Management Survey.
- Published in:
- Clinical & Experimental Nephrology, 2020, v. 24, n. 11, p. 1025, doi. 10.1007/s10157-020-01924-6
- By:
- Publication type:
- Article
High-normal albuminuria is strongly associated with incident chronic kidney disease in a nondiabetic population with normal range of albuminuria and normal kidney function.
- Published in:
- Clinical & Experimental Nephrology, 2020, v. 24, n. 5, p. 435, doi. 10.1007/s10157-019-01842-2
- By:
- Publication type:
- Article
The association between uric acid levels and renal function of CKD patients with hyperlipidemia: a sub-analysis of the ASUCA trial.
- Published in:
- Clinical & Experimental Nephrology, 2020, v. 24, n. 5, p. 420, doi. 10.1007/s10157-019-01840-4
- By:
- Publication type:
- Article
Obstructive sleep apnea as a risk factor for incident end stage renal disease: a nationwide population-based cohort study from Korea.
- Published in:
- Clinical & Experimental Nephrology, 2019, v. 23, n. 12, p. 1391, doi. 10.1007/s10157-019-01779-6
- By:
- Publication type:
- Article
Ratio of triglyceride to high-density lipoprotein cholesterol and risk of major cardiovascular events in kidney transplant recipients.
- Published in:
- Clinical & Experimental Nephrology, 2019, v. 23, n. 12, p. 1407, doi. 10.1007/s10157-019-01776-9
- By:
- Publication type:
- Article
Rationale and study design of a clinical trial to assess the effects of LDL apheresis on proteinuria in diabetic patients with severe proteinuria and dyslipidemia.
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 3, p. 591, doi. 10.1007/s10157-017-1488-4
- By:
- Publication type:
- Article
Impact of low-density lipoprotein cholesterol on decline in estimated glomerular filtration rate in apparently healthy young to middle-aged working men.
- Published in:
- Clinical & Experimental Nephrology, 2018, v. 22, n. 1, p. 15, doi. 10.1007/s10157-017-1407-8
- By:
- Publication type:
- Article
Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial.
- Published in:
- Clinical & Experimental Nephrology, 2017, v. 21, n. 3, p. 417, doi. 10.1007/s10157-016-1304-6
- By:
- Publication type:
- Article
Hypomagnesemia and atherogenic dyslipidemia in chronic kidney disease: surrogate markers for increased cardiovascular risk.
- Published in:
- Clinical & Experimental Nephrology, 2015, v. 19, n. 6, p. 1054, doi. 10.1007/s10157-015-1097-z
- By:
- Publication type:
- Article
Immediate therapeutic efficacy of low-density lipoprotein apheresis for drug-resistant nephrotic syndrome: evidence from the short-term results from the POLARIS Study.
- Published in:
- Clinical & Experimental Nephrology, 2015, v. 19, n. 3, p. 379, doi. 10.1007/s10157-014-0996-8
- By:
- Publication type:
- Article
Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathy.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 4, p. 584, doi. 10.1007/s10157-013-0922-5
- By:
- Publication type:
- Article
Dyslipidemia and progression of kidney disease: role of lipid-lowering drugs.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 2, p. 291, doi. 10.1007/s10157-014-0934-9
- By:
- Publication type:
- Article
Treatment and impact of dyslipidemia in diabetic nephropathy.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 2, p. 201, doi. 10.1007/s10157-013-0898-1
- By:
- Publication type:
- Article
In vivo kinetic studies to further understand pathogenesis of abnormal lipoprotein metabolism in chronic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 2, p. 261, doi. 10.1007/s10157-013-0881-x
- By:
- Publication type:
- Article
Abnormal lipoprotein metabolism in diabetic nephropathy.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 2, p. 206, doi. 10.1007/s10157-013-0880-y
- By:
- Publication type:
- Article
Beneficial effect of LDL-apheresis in refractory nephrotic syndrome.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 2, p. 286, doi. 10.1007/s10157-013-0930-5
- By:
- Publication type:
- Article
Epidemiology of dyslipidemia in chronic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 2, p. 185, doi. 10.1007/s10157-013-0891-8
- By:
- Publication type:
- Article
Statins in chronic kidney disease: what do meta-analyses tell us?
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 2, p. 278, doi. 10.1007/s10157-013-0889-2
- By:
- Publication type:
- Article
Role of dyslipidemia in impairment of energy metabolism, oxidative stress, inflammation and cardiovascular disease in chronic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2014, v. 18, n. 2, p. 265, doi. 10.1007/s10157-013-0847-z
- By:
- Publication type:
- Article
The kidney and lipids: preface.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: Rationale and design of the ASsessment of clinical Usefulness in CKD patients with Atorvastatin (ASUCA) trial.
- Published in:
- Clinical & Experimental Nephrology, 2013, v. 17, n. 2, p. 211, doi. 10.1007/s10157-012-0676-5
- By:
- Publication type:
- Article
Serum non-high-density lipoprotein cholesterol (non-HDL-C) levels and cardiovascular mortality in chronic hemodialysis patients.
- Published in:
- Clinical & Experimental Nephrology, 2012, v. 16, n. 5, p. 767, doi. 10.1007/s10157-012-0615-5
- By:
- Publication type:
- Article
Clinical assessment and management of dyslipidemia in patients with chronic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2012, v. 16, n. 4, p. 522, doi. 10.1007/s10157-012-0655-x
- By:
- Publication type:
- Article